Hybrid Business Model
Aphios operates through a dual strategy: developing proprietary therapeutics and licensing enabling technologies. We hold 87 issued U.S. and international patents, 40 pending applications, and multiple trademarks. Our scalable structure includes Special Purpose Vehicles (SPVs) and LLCs that drive focused product development and financing:
- Zindol® LLC: Developing Zindol® for chemotherapy-induced and pregnancy-related nausea and vomiting. Target market: $3.4B.
- Amylon™ LLC: Commercializing nanoencapsulated Bryoids for Alzheimer’s and dementia. Target market: $19B (by 2030).
- Bryolat™: Advancing nanoparticle HIV-1 latency therapy aimed at a functional cure. Target market: $58B (by 2032).
- Aphios® Pharma LLC: Delivering pharmaceutical-grade, cannabinoid-based drugs for pain, anxiety, and MS. Target market: $93B (by 2033).
- Aphios® International LLC: Developing CFI® pathogen reduction technology for biologics and plasma. Target market: $2.5B.
Aphios® Pharma LLC
Our subsidiary, Aphios® Pharma LLC, is developing cannabis-based drugs for addiction, cancer pain, and anxiety. While medical marijuana may help, its effects are often inconsistent and short-lived. The market—valued at $93 billion—is underserved by current cannabis-based drugs designed for acute use rather than chronic treatment. One notable example is Epidiolex, a drug for childhood epilepsy developed by GW Pharma and acquired by Jazz Pharmaceuticals for $7.2 billion.
Aphios differentiates itself by using patented nanotechnology to sustain cannabinoid release in the body, targeting chronic conditions such as pain, anxiety, and addiction.
Join Our Mailing List
Stay up to date with Aphios by subscribing to our mailing list! Get the latest news on innovative therapies and advancements in pharmaceutical development.
Our Products
Developing Natural Solutions for Human Health®
Inspired by Nature, Enabled by Science®, we are leading the way in developing enhanced therapeutics for health maintenance, disease prevention, and the treatment of certain cancers and supportive care, infectious diseases such as HIV and influenza, and CNS disorders including Alzheimer’s disease, MS, addiction, pain and anxiety.
Our Technology
Taking Nature’s Wisdom to a Higher Level®
Using advanced scientific techniques, we are improving nanotechnology drug delivery, accelerating the drug discovery and manufacturing process, removing harmful pathogens from biologics and the human blood supply and working to provide a viable biofuel solution for the future.
Partnering Opportunities
Partnering for the Future of Human Health®
We are seeking partners and investors to further the development and utilization of our enabling technology platforms and enhanced therapeutic products. We are interested in working with individuals and companies dedicated to improving quality of life, maintaining health and treating unmet medical needs and chronic diseases.
